Azimuth Capital Management’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | $10.4M | Sell |
142,877
-5,142
| -3% | -$345K | 0.45% | 77 |
|
|
2021
Q4 | $9.23M | Sell |
148,019
-3,255
| -2% | -$191K | 0.37% | 103 |
|
|
2021
Q3 | $8.95M | Buy |
151,274
+145
| +0.1% | +$9.55K | 0.38% | 99 |
|
|
2021
Q2 | $10.1M | Sell |
151,129
-1,508
| -1% | -$98.3K | 0.44% | 83 |
|
|
2021
Q1 | $9.64M | Buy |
152,637
+665
| +0.4% | +$41.4K | 0.46% | 79 |
|
|
2020
Q4 | $9.43M | Sell |
151,972
-3,605
| -2% | -$222K | 0.47% | 78 |
|
|
2020
Q3 | $9.38M | Sell |
155,577
-1,040
| -0.7% | -$62.6K | 0.55% | 70 |
|
|
2020
Q2 | $9.21M | Buy |
156,617
+420
| +0.3% | +$25.1K | 0.59% | 61 |
|
|
2020
Q1 | $8.71M | Sell |
156,197
-1,035
| -0.7% | -$63.3K | 0.65% | 55 |
|
|
2019
Q4 | $10.1M | Sell |
157,232
-1,454
| -0.9% | -$83.3K | 0.61% | 62 |
|
|
2019
Q3 | $8.05M | Buy |
158,686
+3,212
| +2% | +$151K | 0.52% | 75 |
|
|
2019
Q2 | $7.05M | Buy |
155,474
+7,945
| +5% | +$370K | 0.47% | 77 |
|
|
2019
Q1 | $7.04M | Buy |
147,529
+17,625
| +14% | +$878K | 0.47% | 74 |
|
|
2018
Q4 | $6.75M | Buy |
129,904
+1,191
| +0.9% | +$64K | 0.52% | 65 |
|
|
2018
Q3 | $7.99M | Buy |
128,713
+2,750
| +2% | +$163K | 0.54% | 72 |
|
|
2018
Q2 | $6.97M | Buy |
125,963
+12,705
| +11% | +$686K | 0.5% | 79 |
|
|
2018
Q1 | $7.16M | Sell |
113,258
-750
| -0.7% | -$48.2K | 0.53% | 73 |
|
|
2017
Q4 | $6.99M | Sell |
114,008
-10,675
| -9% | -$668K | 0.5% | 77 |
|
|
2017
Q3 | $7.95M | Sell |
124,683
-1,927
| -2% | -$113K | 0.59% | 61 |
|
|
2017
Q2 | $7.05M | Buy |
126,610
+1,058
| +0.8% | +$57.6K | 0.56% | 70 |
|
|
2017
Q1 | $6.83M | Sell |
125,552
-57,421
| -31% | -$3.15M | 0.55% | 68 |
|
|
2016
Q4 | $10.7M | Sell |
182,973
-35,717
| -16% | -$1.95M | 0.91% | 24 |
|
|
2016
Q3 | $11.8M | Buy |
218,690
+4,265
| +2% | +$274K | 1.03% | 22 |
|
|
2016
Q2 | $15.8M | Buy |
214,425
+40,699
| +23% | +$2.88M | 1.41% | 9 |
|
|
2016
Q1 | $11.1M | Buy |
173,726
+43,055
| +33% | +$2.72M | 1.06% | 17 |
|
|
2015
Q4 | $8.99M | Sell |
130,671
-780
| -0.6% | -$51.5K | 0.88% | 31 |
|
|
2015
Q3 | $7.78M | Sell |
131,451
-5,300
| -4% | -$336K | 0.82% | 38 |
|
|
2015
Q2 | $9.1M | Sell |
136,751
-7,156
| -5% | -$472K | 0.88% | 27 |
|
|
2015
Q1 | $9.28M | Sell |
143,907
-850
| -0.6% | -$53.2K | 0.9% | 26 |
|
|
2014
Q4 | $8.54M | Sell |
144,757
-4,750
| -3% | -$268K | 0.88% | 28 |
|
|
2014
Q3 | $7.65M | Sell |
149,507
-7,405
| -5% | -$370K | 0.84% | 28 |
|
|
2014
Q2 | $7.61M | Sell |
156,912
-270
| -0.2% | -$13.3K | 0.85% | 28 |
|
|
2014
Q1 | $8.17M | Sell |
157,182
-28,061
| -15% | -$1.49M | 0.99% | 20 |
|
|
2013
Q4 | $9.85M | Buy |
185,243
+32,170
| +21% | +$1.64M | 1.17% | 14 |
|
|
2013
Q3 | $7.08M | Buy |
153,073
+48,543
| +46% | +$2.13M | 0.97% | 21 |
|
|
2013
Q2 | $4.67M | Buy |
+104,530
| New | +$4.54M | 0.82% | 35 |
|
Other funds holding BMY
Azimuth Capital Management's BMY Position: Q1 2022 in Review
Azimuth Capital Management reduced its Bristol-Myers Squibb (BMY) stake by 3.5% in Q1 2022, selling an estimated $345K and leaving 142,877 shares worth $10.4M. The position accounts for 0.45% of the portfolio, ranked #77.
Azimuth Capital Management first reported a position in BMY in Q2 2013 and has held it in 36 quarters since. The position peaked at $15.8M in Q2 2016. 2,515 funds tracked by Wall St. Rank hold BMY as of Q1 2022.
- Azimuth Capital Management held 142,877 shares of Bristol-Myers Squibb worth $10.4M as of Q1 2022.
- Azimuth Capital Management sold 5,142 Bristol-Myers Squibb shares in Q1 2022, an estimated $345K.
- Bristol-Myers Squibb made up 0.45% of Azimuth Capital Management's portfolio in Q1 2022, its #77 holding.
- Azimuth Capital Management first reported a position in Bristol-Myers Squibb in Q2 2013 and has held it in 36 quarters since.
- Azimuth Capital Management's Bristol-Myers Squibb position peaked at $15.8M in Q2 2016.
- 2,515 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2022.
Based on Azimuth Capital Management's 13F filing for Q1 2022, filed 13 May 2022.